209 related articles for article (PubMed ID: 19016377)
1. Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity.
Roy A; Hooper DC
J Neurovirol; 2008 Oct; 14(5):401-11. PubMed ID: 19016377
[TBL] [Abstract][Full Text] [Related]
2. Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection.
Roy A; Phares TW; Koprowski H; Hooper DC
J Virol; 2007 Feb; 81(3):1110-8. PubMed ID: 17108029
[TBL] [Abstract][Full Text] [Related]
3. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier.
Roy A; Hooper DC
J Virol; 2007 Aug; 81(15):7993-8. PubMed ID: 17507463
[TBL] [Abstract][Full Text] [Related]
4. The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system.
Hooper DC; Phares TW; Fabis MJ; Roy A
PLoS Negl Trop Dis; 2009 Oct; 3(10):e535. PubMed ID: 19806203
[TBL] [Abstract][Full Text] [Related]
5. T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue.
Lebrun A; Portocarrero C; Kean RB; Barkhouse DA; Faber M; Hooper DC
J Immunol; 2015 Nov; 195(9):4358-68. PubMed ID: 26408670
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.
Fabis MJ; Phares TW; Kean RB; Koprowski H; Hooper DC
Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15511-6. PubMed ID: 18829442
[TBL] [Abstract][Full Text] [Related]
7. Mannitol treatment is not effective in therapy of rabies virus infection in mice.
Dufkova L; Sirmarova J; Salat J; Honig V; Palus M; Ruzek D; Fooks AR; Mansfield KL; Tordo N; Jochmans D; Neyts J; Martina B; Koraka P; Osterhaus ADME;
Vaccine; 2019 Aug; 37(33):4710-4714. PubMed ID: 29274698
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection.
Chai Q; He WQ; Zhou M; Lu H; Fu ZF
J Virol; 2014 May; 88(9):4698-710. PubMed ID: 24522913
[TBL] [Abstract][Full Text] [Related]
9. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system.
Phares TW; Kean RB; Mikheeva T; Hooper DC
J Immunol; 2006 Jun; 176(12):7666-75. PubMed ID: 16751414
[TBL] [Abstract][Full Text] [Related]
10. Rabies virus glycoprotein is an important determinant for the induction of innate immune responses and the pathogenic mechanisms.
Zhang G; Wang H; Mahmood F; Fu ZF
Vet Microbiol; 2013 Mar; 162(2-4):601-613. PubMed ID: 23265241
[TBL] [Abstract][Full Text] [Related]
11. Rabies virus clearance from the central nervous system.
Hooper DC; Roy A; Barkhouse DA; Li J; Kean RB
Adv Virus Res; 2011; 79():55-71. PubMed ID: 21601042
[TBL] [Abstract][Full Text] [Related]
12. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system.
Wang ZW; Sarmento L; Wang Y; Li XQ; Dhingra V; Tseggai T; Jiang B; Fu ZF
J Virol; 2005 Oct; 79(19):12554-65. PubMed ID: 16160183
[TBL] [Abstract][Full Text] [Related]
13. Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues.
Li J; Ertel A; Portocarrero C; Barkhouse DA; Dietzschold B; Hooper DC; Faber M
J Virol; 2012 Mar; 86(6):3200-10. PubMed ID: 22238315
[TBL] [Abstract][Full Text] [Related]
14. Sufficient virus-neutralizing antibody in the central nerve system improves the survival of rabid rats.
Liao PH; Yang HH; Chou PT; Wang MH; Chu PC; Liu HL; Chen LK
J Biomed Sci; 2012 Jun; 19(1):61. PubMed ID: 22734518
[TBL] [Abstract][Full Text] [Related]
15. Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus.
Faber M; Li J; Kean RB; Hooper DC; Alugupalli KR; Dietzschold B
Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11300-5. PubMed ID: 19581599
[TBL] [Abstract][Full Text] [Related]
16. Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers.
Preuss MA; Faber ML; Tan GS; Bette M; Dietzschold B; Weihe E; Schnell MJ
PLoS Pathog; 2009 Jun; 5(6):e1000485. PubMed ID: 19543379
[TBL] [Abstract][Full Text] [Related]
17. Role of the blood-brain barrier in rabies virus infection and protection.
Wang L; Cao Y; Tang Q; Liang G
Protein Cell; 2013 Dec; 4(12):901-3. PubMed ID: 24264143
[TBL] [Abstract][Full Text] [Related]
18. Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant.
Garcia SA; Lebrun A; Kean RB; Craig Hooper D
J Neurovirol; 2018 Oct; 24(5):606-615. PubMed ID: 29987584
[TBL] [Abstract][Full Text] [Related]
19. Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice.
Yan X; Prosniak M; Curtis MT; Weiss ML; Faber M; Dietzschold B; Fu ZF
J Neurovirol; 2001 Dec; 7(6):518-27. PubMed ID: 11704884
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice.
Huang CT; Li Z; Huang Y; Zhang G; Zhou M; Chai Q; Wu H; Fu ZF
Antiviral Res; 2014 Oct; 110():132-41. PubMed ID: 25108172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
